PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

Phase III study finds perioperative nivolumab plus chemotherapy significantly lowers chance of disease recurrence, progression or death compared to chemotherapy alone

Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
2024-05-15
(Press-News.org) Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer(NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center.

Results from the Phase III CheckMate 77T study were published today in the New England Journal of Medicine. At a median follow-up of 25.4 months, the median EFS with chemotherapy alone was 18.4 months, while the median had not yet been reached for patients receiving perioperative nivolumab, meaning EFS was prolonged significantly over the control group. These results correspond to a 42% reduction in risk of disease progression, recurrence, or death for those receiving the perioperative combination.

This data was first presented at the 2023 European Society for Medical Oncology (ESMO) Congress.

Patients who received the perioperative nivolumab-based regimen also saw significantly higher rates of pathological complete response (pCR), defined as no tumor remaining at surgery, compared with those who received chemotherapy alone (25.3% vs. 4.7%). Rates of major pathological response (MPR), less than or equal to 10% of viable tumor cells remaining at time of surgery, were also higher in patients who received perioperative immunotherapy (35.4% vs. 12.1%).

“This study builds on the standard-of-care neoadjuvant chemoimmunotherapy treatment and supports perioperative nivolumab as an effective approach that reduces the risk of lung cancer relapse,” said principal investigator Tina Cascone, M.D., Ph.D., associate professor of Thoracic/Head & Neck Medical Oncology. “These findings add to evidence that the perioperative immunotherapy path gives patients with operable lung cancer an opportunity to live longer without their cancer returning.”

Roughly 30% of patients diagnosed with NSCLC have operable disease, meaning their tumor can be removed by a surgical operation. While many of these patients can be potentially cured by surgery, more than half will experience cancer recurrence without additional therapy. Chemotherapy given either before or after surgery provides only a minimal survival benefit.

The randomized, double-blind CheckMate 77T trial, which began in 2019, included more than 450 NSCLC patients over the age of 18 from around the globe. Participants were randomized to treatment with either neoadjuvant nivolumab with chemotherapy followed by surgery and adjuvant nivolumab, or neoadjuvant chemotherapy and placebo followed by surgery and adjuvant placebo

The data showed no new safety signals with the perioperative nivolumab regimen and is consistent with the known safety profiles of individual agents. Grade 3-4 treatment-related side effects were observed in 32% and 25% of patients receiving the perioperative combination or control therapy, respectively. Surgery-related adverse events occurred in 12% of patients in both treatment arms.

These findings add to recent success seen with neoadjuvant nivolumab plus chemotherapy in NSCLC. In March 2022, the Phase III CheckMate 816 study led to FDA approval of nivolumab combined with platinum-based chemotherapy.

“I am enthusiastic about the initial findings of the study,” Cascone said. “Looking ahead, it will be critical to identify patient and disease characteristics that will tell us who can potentially be cured with neoadjuvant chemoimmunotherapy only and who will benefit from more intensified treatment strategies.”

The CheckMate 77T study was sponsored by Bristol Myers Squibb. A full list of co-authors and author disclosures can be found here.

Read the full release in the MD Anderson Newsroom.

END

[Attachments] See images for this press release:
Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

ELSE PRESS RELEASES FROM THIS DATE:

'Trojan horse' weight loss drug more effective than available therapies

2024-05-15
“I consider the drugs available on the marked today as the first generation of weight-loss drugs. Now we have developed a new type of weight-loss drug that affects the plasticity of the brain and appears to be highly effective.” So says Associate Professor and Group Leader Christoffer Clemmensen, from the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen, who is senior author of the new study, which has been published in the prestigious scientific journal Nature. In the study, Christoffer Clemmensen and colleagues demonstrate a new use of the weight loss hormone GLP-1. GLP-1 can be used as a ‘Trojan ...

Reduced risk of breast cancer following bariatric surgery in women with hyperinsulinemia

Reduced risk of breast cancer following bariatric surgery in women with hyperinsulinemia
2024-05-15
Bariatric surgery is associated with a reduced risk of breast cancer in women with obesity. These are the findings of a study conducted at the University of Gothenburg. The risk reduction is greatest for those with high blood insulin levels at the time of surgery. The study, published in JAMA Surgery, is based on data from 2,867 women with obesity, half of whom had undergone bariatric surgery at 25 surgical departments. The remaining women, comprising the control group, received standard obesity treatment at 480 healthcare centers. The groups were otherwise comparable in terms of age and body composition. The results show that a total of ...

Copper can't be mined fast enough to electrify the US

2024-05-15
Copper cannot be mined quickly enough to keep up with current U.S. policy guidelines to transition the country's electricity and vehicle infrastructure to renewable energy, according to a University of Michigan study.   The Inflation Reduction Act, signed into law in 2022, calls for 100% of cars manufactured to be electric vehicles by 2035. But an electric vehicle requires three to five times as much copper as an internal combustion engine vehicle—not to mention the copper required for upgrades to the electric grid.     "A ...

Guideline issued for people with epilepsy who may become pregnant

2024-05-15
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, MAY 15, 2024 MINNEAPOLIS – A new guideline has been issued to help neurologists and other clinicians determine the best antiseizure medications for people with epilepsy who may become pregnant. The guideline is published in the May 15, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology (AAN), and was developed through a collaboration between the AAN, the American Epilepsy Society (AES) and the Society for Maternal-Fetal Medicine (SMFM). It was endorsed by the Child Neurology Society. The guideline partially updates two 2009 AAN and AES ...

Only 20% of U.S. nonprofit hospitals invested in housing as part of the federal community benefit mandate

2024-05-15
Waltham — May 15, 2024 — A nationwide assessment of how nonprofit hospitals are addressing housing-related needs in their communities appears in the latest issue of Medical Care, the official journal of the Medical Care Section of the American Public Health Association. The journal is published in the Lippincott portfolio by Wolters Kluwer.  "Approximately 60% of hospitals in the United States are 501(c)(3) nonprofit organizations ...

The crystallization of memory: Study reveals how practice forms new memory pathways in the brain

2024-05-15
A new study led by UCLA Health has shown that repetitive practice not only is helpful in improving skills but also leads to profound changes in the brain’s memory pathways. The research, published in the journal Nature and co-led by Rockefeller University, sought to unravel how the brain’s ability to retain and process information, known as working memory, improves through training. To test this, researchers tasked mice with identifying and recalling a sequence of odors over the course of two weeks. Researchers then tracked neural activity in the animals as they practiced the task by using a novel, custom-built microscope that can image cellular activity ...

Dartmouth-led study provides new insights into phage therapy design

2024-05-15
Results from a new Dartmouth-led study, involving collaborators at the University of Pittsburgh and Yale University and published in the journal PLOS Biology, are providing new insights into the therapeutic potential of bacteriophage (phage) therapy for treating diseases like cystic fibrosis (CF).    A major challenge of treating people with CF—an inherited disease that causes sticky, thick mucus to build up in the lungs—are the persistent infections the disease causes which can lead to respiratory failure and death.    “Opportunistic ...

This time, it’s personal: Enhancing patient response to cancer immunotherapy

This time, it’s personal: Enhancing patient response to cancer immunotherapy
2024-05-15
LA JOLLA (May 15, 2024)—Immunotherapy has revolutionized the way we treat cancer in recent years. Instead of targeting the tumor itself, immunotherapies work by directing patients’ immune systems to attack their tumors more effectively. This has been especially impactful in improving outcomes for certain difficult-to-treat cancers. Still, fewer than half of all cancer patients respond to current immunotherapies, creating an urgent need to identify biomarkers that can predict which patients are most likely to benefit. Recently, scientists have noticed that patients whose tumors have a mutation in a gene called ARID1A are ...

A novel multifunctional catalyst turns methane into valuable hydrocarbons

A novel multifunctional catalyst turns methane into valuable hydrocarbons
2024-05-15
Methane, a greenhouse gas that contributes significantly towards global warming, is also an important source of energy and an essential chemical resource. When used as a chemical feedstock, methane is typically converted into methanol first and then into hydrocarbons. However, this sequential conversion requires complex industrial setups. More importantly, since methane is a very stable molecule, its conversion into methanol requires tremendous amounts of energy when using conventional means, such ...

Two decades of studies suggest health benefits associated with plant-based diets

Two decades of studies suggest health benefits associated with plant-based diets
2024-05-15
Vegetarian and vegan diets are generally associated with better status on various medical factors linked to cardiovascular health and cancer risk, as well as lower risk of cardiovascular diseases, cancer, and death, according to a new review of 49 previously published papers. Angelo Capodici and colleagues present these findings in the open-access journal PLOS ONE on May 15, 2024. Prior studies have linked certain diets with increased risk of cardiovascular disease and cancer. A diet that is poor in plant products and rich in meat, refined grains, sugar, and salt is associated with higher risk of death. Reducing consumption of animal-based ...

LAST 30 PRESS RELEASES:

Community partners key to success of vaccine clinic focused on neurodevelopmental conditions

Low-carbon collaborative dual-layer optimization for energy station considering joint electricity and heat demand response

McMaster University researchers uncover potential treatment for rare genetic disorders

The return of protectionism: The impact of the Sino-US trade war

UTokyo and NARO develop new vertical seed distribution trait for soybean breeding

Research into UK’s use of plastic packaging finds households ‘wishcycle’ rather than recycle – risking vast contamination

Vaccine shows promise against aggressive breast cancer

Adverse events affect over 1 in 3 surgery patients, US study finds

Outsourcing adult social care has contributed to England’s care crisis, argue experts

The Lancet: Over 800 million adults living with diabetes, more than half not receiving treatment, global study suggests

New therapeutic approach for severe COVID-19: faster recovery and reduction in mortality

Plugged wells and reduced injection lower induced earthquake rates in Oklahoma

Yin selected as a 2024 American Society of Agronomy Fellow

Long Covid could cost the economy billions every year

Bluetooth technology unlocks urban animal secrets

This nifty AI tool helps neurosurgeons find sneaky cancer cells

Treatment advances, predictive biomarkers stand to improve bladder cancer care

NYC's ride-hailing fee failed to ease Manhattan traffic, new NYU Tandon study reveals

Meteorite contains evidence of liquid water on Mars 742 million years ago

Self-reported screening helped reduce distressing symptoms for pediatric patients with cancer

Which risk factors are linked to having a severe stroke?

Opening borders for workers: Abe’s profound influence on Japan’s immigration regime

How skills from hospitality and tourism can propel careers beyond the industry

Research shows managers of firms handling recalls should review media scrutiny before deciding whether to lobby

New model system for the development of potential active substances used in condensate modifying drugs

How to reduce social media stress by leaning in instead of logging off

Pioneering research shows sea life will struggle to survive future global warming

In 10 seconds, an AI model detects cancerous brain tumor often missed during surgery 

Burden of RSV–associated hospitalizations in US adults, October 2016 to September 2023

Repurposing semaglutide and liraglutide for alcohol use disorder

[Press-News.org] Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
Phase III study finds perioperative nivolumab plus chemotherapy significantly lowers chance of disease recurrence, progression or death compared to chemotherapy alone